Cue Biopharma Inc (CUE)
1.395
+0.02
(+1.09%)
USD |
NASDAQ |
Jun 27, 16:00
1.38
-0.02
(-1.08%)
After-Hours: 16:42
Cue Biopharma Accounts Receivable (Quarterly): 1.40M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.40M |
December 31, 2023 | 1.698M |
September 30, 2023 | 1.661M |
June 30, 2023 | 1.135M |
March 31, 2023 | 0.196M |
December 31, 2022 | 0.057M |
September 30, 2022 | 0.796M |
June 30, 2022 | 0.736M |
March 31, 2022 | 0.925M |
December 31, 2021 | 3.142M |
September 30, 2021 | 0.771M |
Date | Value |
---|---|
June 30, 2021 | 1.904M |
March 31, 2021 | 1.413M |
December 31, 2020 | 1.418M |
September 30, 2020 | 0.457M |
June 30, 2020 | 1.228M |
March 31, 2020 | 0.605M |
December 31, 2019 | 0.7549M |
September 30, 2019 | 0.61M |
June 30, 2019 | 0.522M |
March 31, 2019 | |
December 31, 2018 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.057M
Minimum
Dec 2022
3.142M
Maximum
Dec 2021
1.071M
Average
0.8605M
Median
Accounts Receivable (Quarterly) Benchmarks
XOMA Corp | 0.003M |
Ardelyx Inc | 28.16M |
NovaBay Pharmaceuticals Inc | 0.734M |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |